BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 15482343)

  • 1. Clinical characteristics and outcome of patients with cirrhosis and refractory ascites.
    Moreau R; Delègue P; Pessione F; Hillaire S; Durand F; Lebrec D; Valla DC
    Liver Int; 2004 Oct; 24(5):457-64. PubMed ID: 15482343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma.
    Cantarini MC; Trevisani F; Morselli-Labate AM; Rapaccini G; Farinati F; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M;
    Am J Gastroenterol; 2006 Jan; 101(1):91-8. PubMed ID: 16405539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic factors for survival in cirrhosis].
    Ennaifer R; Ouakaa-Kchaou A; BelHadj N; Elloumi H; Gargouri D; Kochlef A; Kilani A; Romani M; Kharrat J; Ghorbel A
    Tunis Med; 2007 Dec; 85(12):1039-43. PubMed ID: 19170384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
    Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
    Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt.
    Guardiola J; Xiol X; Escribá JM; Castellví JM; Castellote J; Baliellas C; Rafecas A; Casais LA
    Am J Gastroenterol; 1995 Dec; 90(12):2097-102. PubMed ID: 8540495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients.
    Salerno F; Borroni G; Moser P; Badalamenti S; Cassarà L; Maggi A; Fusini M; Cesana B
    Am J Gastroenterol; 1993 Apr; 88(4):514-9. PubMed ID: 8470631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modified CLIP score as a new prognostic index for patients with hepatocellular carcinoma].
    Han SH; Han SY; Go BS; Kim MJ; Lee JH; Koo YH; Ryu SH; Cho JH; Jang JS; Lee JH; Roh MH; Choi SR; Choi JC; Lee SW
    Korean J Hepatol; 2006 Jun; 12(2):209-20. PubMed ID: 16804346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
    Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma.
    Huo TI; Hsu CY; Huang YH; Hsia CY; Lin HC; Lee PC; Loong CC; Chiang JH; Chiou YY; Lee SD
    Liver Int; 2010 Feb; 30(2):198-207. PubMed ID: 19849777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma.
    Kikuchi LO; Paranaguá-Vezozzo DC; Chagas AL; Mello ES; Alves VA; Farias AQ; Pietrobon R; Carrilho FJ
    J Clin Gastroenterol; 2009 Feb; 43(2):191-5. PubMed ID: 19142170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.
    Ishizawa T; Hasegawa K; Aoki T; Takahashi M; Inoue Y; Sano K; Imamura H; Sugawara Y; Kokudo N; Makuuchi M
    Gastroenterology; 2008 Jun; 134(7):1908-16. PubMed ID: 18549877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of survival in complicated viral and alcoholic cirrhosis without hepatocellular carcinoma. A retrospective study.
    Spadaro A; Luigiano C; De Caro G; Morace C; Tortorella V; Bonfiglio C; Pagano N; Consolo P; Alibrandi A; Ajello A; Ferraù O; Freni MA
    Minerva Gastroenterol Dietol; 2007 Dec; 53(4):311-9. PubMed ID: 18043549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation of a prognostic model for predicting survival of cirrhotic patients with refractory ascites.
    Guardiola J; Baliellas C; Xiol X; Fernandez Esparrach G; Ginès P; Ventura P; Vazquez S
    Am J Gastroenterol; 2002 Sep; 97(9):2374-8. PubMed ID: 12358259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment for hepatocellular carcinoma patients with severe cirrhosis--a report of 67 cases].
    Hong J; Yuan YF; Li BK; Huang L; Li JQ; Zhang YQ; Li GH
    Ai Zheng; 2007 Jun; 26(6):620-3. PubMed ID: 17562268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.
    Wörns MA; Weinmann A; Pfingst K; Schulte-Sasse C; Messow CM; Schulze-Bergkamen H; Teufel A; Schuchmann M; Kanzler S; Düber C; Otto G; Galle PR
    J Clin Gastroenterol; 2009; 43(5):489-95. PubMed ID: 19247201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and prognostic factors in patients with hepatocellular carcinoma.
    Martins A; Cortez-Pinto H; Marques-Vidal P; Mendes N; Silva S; Fatela N; Glória H; Marinho R; Távora I; Ramalho F; de Moura MC
    Liver Int; 2006 Aug; 26(6):680-7. PubMed ID: 16842324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis.
    Cucchetti A; Vivarelli M; Piscaglia F; Nardo B; Montalti R; Grazi GL; Ravaioli M; La Barba G; Cavallari A; Bolondi L; Pinna AD
    J Hepatol; 2005 Aug; 43(2):310-6. PubMed ID: 15970351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
    Teh SH; Sheppard BC; Schwartz J; Orloff SL
    Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.